The experience gained over of all the years and all the students has helped us fine tune our courses into the easiest, most user - friendly online traffic
safety programs in the country.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European
countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs;
safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
«To have an OSHA representative saying that the facility is not only one of the best
in the
country, but the
program itself is something that she feels should be implemented
in some way shape or form at other VPP sites,» said Clean Harbors Regional Health and
Safety Manager Floyd Williams, «It's pretty extraordinary.»
In Muslim
countries, religious groups largely control the «
safety net» of
programs for the poor and administer them.
The BRC Global Standard is a leading product
safety and quality certification
program used by manufacturers
in over 100
countries.
During 2011 - 12 we trained 36 young professionals from 7
countries in Sub-Saharan Africa using an e-learning
program developed and provided by PEF — these postharvest specialists trained more than 13,000 Africa farmers, traders, processors and marketers during 2012 - 13
in a wide range of improved postharvest handling and appropriate food processing / food
safety practices.
Engaging efforts with experts from 47 IDFA member companies and cooperation from other parts of the dairy industry, the Food and Drug Administration (FDA) and state regulators, IDFA advocated for, among other things: reasonable regulations
in the Pasteurized Milk Ordinance (PMO) that align the Interstate Milk Shippers
program with the requirements of the Food
Safety Modernization Act's (FSMA) Preventive Controls for Human Food (PCHF) rule; harmonizing the PMO with an FDA rule on higher fortification levels of vitamin D3 and requiring FDA to be more transparent
in the determination of foreign
country regulatory equivalence with the U.S. Grade «A»
program.
The BRC Global Standard — used by over 23,000 certified suppliers
in 123
countries — is a leading
safety and quality certification
program for the food and beverage sector with certification issued through a worldwide network of accredited certifying bodies, including Cert ID.
If you are involved
in a private youth sports
program which plays on publicly - owned fields, diamonds, rinks, or courts, or are
in local government, you have probably been hearing a lot lately about what is being dubbed the «power of the permit»: the authority municipalities and towns around the
country are using to condition use of their athletic facilities by private
programs on compliance with state concussion
safety laws from which they would otherwise be exempt, or,
in an increasing number of instances, to fill gaps
in their state's law.
In that speech (a full copy of which you can view by clicking here), I offered some suggestions on how each of us — whether we be parent, coach, official, athletic trainer, clinician, current or former professional athlete, sports
safety equipment manufacturer, whether we were there representing a local youth sports
program, the national governing body of a sport, or a professional sports league, could work together as a team to protect our
country's most precious human resource — our children — against catastrophic injury or death from sudden impact syndrome or the serious, life - altering consequences of multiple concussions.
Utah has the best laws and regulations
in the
country for teen help
programs, making it a popular destination for parents seeking quality,
safety and peace of mind.
Population - level effects of vaccination
programs on infection and disease outcomes have exceeded expectations
in many
countries, and extensive
safety evaluations have not identified concerns.
The specter of CWD has also alarmed the European Food
Safety Authority, which released a report
in January recommending that seven nearby
countries all begin 3 - year sampling
programs.
My team at BSRI, and collaborators
in the REDS
programs (the American Red Cross and globally), have responded to numerous blood
safety threats with rigorous studies
in multiple
countries to verify and quantify rates of infected donations, and consequent risks of transmission to and disease outcomes
in recipients.
U.S. State Department travel warning status or other
safety concerns may result
in Democracy Prep suspending
programs and travel
in the affected
countries, and chaperones and scholars may be required to return to the U.S. or relocate to a safer location.
The following list identifies schools and districts throughout the
country where Safe & Civil Schools
programs have made a real difference
in how teachers, students, parents, and community members perceive
safety in their schools.
In accepting his position as President & CEO, Isemann stressed his focus on
safety and high - quality
programs, as well as guiding the organization through the financial challenges that face KidsPeace and other charities across the
country.
These
programs are spread throughout the
country, and address all behavioral highway
safety areas: one recent demonstration project
in New York and Connecticut sought to determine whether hand - held cell phone bans are enforceable, and what legal, administrative or other characteristics make enforcement easier or more difficult.
Active
safety features, fitted as standard
in several
countries, include ESP (Electronic Stability
Program), ABS (anti-lock braking system), Hill Start Assist Control (to prevent roll - back when starting on an incline), VSM (Vehicle Stability Management), Brake Assist System and Emergency Stop Signal.
The National Highway Traffic
Safety Administration has officially given the latest Honda Civic Hatchback the best possible 5 - Star overall * crash test safety rating in the New Car Assessment program, the most trusted safety system in the co
Safety Administration has officially given the latest Honda Civic Hatchback the best possible 5 - Star overall * crash test
safety rating in the New Car Assessment program, the most trusted safety system in the co
safety rating
in the New Car Assessment
program, the most trusted
safety system in the co
safety system
in the
country.
The school offered the world's first Master of Preventive Veterinary Medicine degree
program, addressing population health, public health and food
safety aspects of veterinary practice; graduates now serve
in leadership positions
in animal health services, food
safety and public health
programs in 75
countries.
«The ASPCA actively supports
safety net
programs across the
country, which enable owners to keep their pets
in their own homes by providing services such as access to affordable veterinary care or help with pet - friendly housing,» Dr. Emily Weiss, vice president of research and development for the ASPCA, told The Dodo.
The ASPCA is addressing this issue by establishing and supporting «
safety net»
programs in communities across the
country, and we encourage more communities to consider implementing these types of
programs.
Country Energy saves more than $ 1.4 million
Country Energy initially undertook the Bark Busters Dog
Safety Program as a trial program in one of its r
Program as a trial
program in one of its r
program in one of its regions.
As director of Alaska land and public information
programs for the Alaska Department of Fish and Game and the National Park Service, she has helped shaped policy to build appreciation, awareness, and
safety in bear
country.
And so the conversation is steered towards the next (and still very important) question of timescale, instead of focusing for a moment longer on the very significant fact that the
safety of a 150,000 - well deep disposal
program and all the other hundreds of thousands of wells drilled
in this
country is based on the premise that migration can not happen.
In 1960, a 9.5 - magnitude earthquake struck Chile, after which the
country embarked on a massive earthquake -
safety program and enforcing new building codes.
If you would like to participate
in a driver
safety program to help lower your insurance costs, to remove a traffic violation from your Texas driving record or because you were ordered to do so by a Municipal Judge, City of Hill
Country Village Bexar court, you should ask the Municipal Judge, City of Hill
Country Village Bexar court overseeing your citation and they will be happy to provide you with a list of brick and mortar traffic schools
in and around Municipal Judge, City of Hill
Country Village Bexar when you call into discuss your citation.
A Municipal Judge, City of Hill
Country Village Bexar driver has much to gain by keeping a clean driving record through participation
in a Municipal Judge, City of Hill
Country Village Bexar online driver
safety program such as those offered by Getdefensive.com, beyond simply avoiding a suspended license.
The Texas Education Agency allows Municipal Judge, City of Hill
Country Village Bexar drivers to attend a Municipal Judge, City of Hill
Country Village Bexar driver
safety program, including the Municipal Judge, City of Hill Country Village Bexar online defensive driving courses offered by Getdefensive.com, in order to have up to one traffic violation per year expunged from their Texas Department of Public Safety driving r
safety program, including the Municipal Judge, City of Hill
Country Village Bexar online defensive driving courses offered by Getdefensive.com,
in order to have up to one traffic violation per year expunged from their Texas Department of Public
Safety driving r
Safety driving record.
The Title X National Family Planning
Program is a vital component of this
country's health care
safety net and one of our nation's most effective
programs in reducing unintended pregnancies and providing women's health care to those who need it the most.
In 332 counties across the
country, Planned Parenthood served at least half of the women who rely on
safety net
programs like Medicaid and Title X for their birth control.